Clinical Trials Browser

Breast Neoplasms × camrelizumab × 1 year × Clear all

NCT05582499 2026-05-28

FASCINATE-N

Phase 2 Recruiting

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT07107217 2025-08-17

Camella

Phase 2 Not yet recruiting

Breast Neoplasms